Naloxone is the medication mainly used for reversing opioid overdose including heroine and morphine. Increasing launches of novel products of naloxone is a key factor expected to fuel growth of the global naloxone market in the near future. For instance, the U.S. Food and Drug Administration (FDA), in January 2017, approved NARCAN Nasal Spray 2 mg formulation by Adapt Pharma Inc. for the emergency treatments of suspected or known opioid overdose. Sandoz Canada, a section of Novartis AG, in June 2016, launched the injection of S.O.S. naloxone hydrochloride in Canada. Indivior Inc., an Indivior Plc.’s subsidiary, in July 2017, received the marketing authorization (MA) by French Regulatory Agency ANSM for the novel Nalscue naloxone hydrochloride nasal spray suggested for suspected or characterized opioid overdose emergency treatment within France.
Get Sample Report with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-sample/1804
Increasing opioid overdosing prevalence in developed countries including Canada and the U.S. is expected to rise naloxone’s demand and in turn expected to propel growth of the global naloxone market in the near future. For instance, as per the Centers for Disease Control and Prevention (CDC) published data in 2018, over 630,000 individuals in the U.S. lost their lives from overdose of a drug between 1999 and 2016, in 2016 around 66% among the 63,600 deaths by drug overdose included an opioid. Moreover, as per the same source the deaths caused by opioids overdose (including prescription opioids, fentanyl, and heroin,) was 5x higher in 2016 compared to that in 1999. Favorable scenarios for reimbursement for naloxone products is expected to drive the product adoptions and in turn expected to fuel growth of the global naloxone market during the forecast period.
For instance, the NARCAN nasal spray, an intranasal spray of naloxone by ADAPT Pharma Inc., has massive private and public insurance coverage. ADAPT Pharma Inc., signed an agreement with key insurance companies (including Medicaid) and Pharmacy Benefits Managers for ensuring affordable and reasonable costs for the patient. As per the official website of ADAPT Pharma Inc. over 97% of insured lives in the U.S. have access for the NARCAN Nasal Spray Moreover, the global naloxone market is also expected to register significant growth owing to collective initiatives from private and government organizations to increase the naloxone products’ accessibility for opioid overdose’s emergency treatment.
In 2017, Washington, DC and 47 states in the U.S. relaxed access for naloxone by legislation permitting prescriptions to the people who can possibly encounter some person who may be overdosed on drugs. Ontario government, in 2017, provided kits of naloxone to fire departments and police for managing opioid overdose’s emergency case. Government provided naloxone kits to the entire 61 police services along with 447 fire departments within the Ontario.
Want to “ahead” with your competiors request a PDF Brochure with Latest Insights @
https://www.coherentmarketinsights.com/insight/request-pdf/1804
Key Takeaways of the Naloxone Market:
The global naloxone market is expected to expand at an 11.4% CAGR during the forecast period (2021 – 2028), due to constant product approvals, and launches, novel biopharmaceutical products’ robust pipeline.
North America is expected to account for the highest share in the global naloxone market during the forecast period (2021 – 2028). This is owing to high opioid overdose rates and owing to unique naloxone products present including Nacran nasal spray within the region. For instance, Adapt Pharma Inc., in February, commercially introduced the Narcan nasal spray 4mg within the U.S. market.
Europe is expected to register robust growth in the global naloxone market, owing to rising novel naloxone product approvals in this region. For instance, Indivior Inc., in July 2017, an Indivior Plc.’ subsidiary, received the marketing authorization (MA) by French Regulatory Agency ANSM for the novel Nalscue naloxone hydrochloride nasal spray suggested for suspected or characterized opioid overdose emergency treatment within France
Moreover, initiatives by manufacturers along with regulatory organizations for increasing access for the naloxone products in emergency cases is expected to accelerate growth of the global naloxone market during the forecast period. For instance, in the U.S. 47 states along with Washington, DC, in 2017, have expanded the access for naloxone by legislation which permits prescriptions for individuals who could possibly com across someone who may be overdosed with drug.
Key players functioning in the global naloxone market are Mylan N.V., Indivior Plc., Novartis AG, ADAPT Pharma, Inc., INSYS Therapeutics, Inc., Amphastar Pharmaceuticals, Inc., Mundipharma International Limited, Kern Pharma, S.L., and Kaleo, Inc.
Reasons to Purchase this Report
• Current and future of global Naloxone market outlook in the developed and emerging markets
• The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period.
• Regions/countries that are expected to witness the fastest growth rates during the forecast period
• The latest developments, market shares, and strategies that are employed by the major market players
Table of Contents
- Research Objective and Assumption
- Research Objectives
- Assumptions
- Abbreviations
- Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Strength
- Market Snippet, By Route of Administration
- Market Snippet, By Distribution Channel
- Market Snippet, By Region
- Coherent Opportunity Map (COM)
- Report Description
- Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Product Approvals/Launch
- Pipeline Analysis
- Regulatory Scenario
- Reimbursement Scenario
- Dosage Variation
- Pricing Analysis
- Supply Chain Analysis
- Market Dynamics
- Global Naloxone Market, By Strength, 2016 – 2026 (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- 0.4 mg/ml
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- 1mg/ml
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- 0.4mg/0.4ml
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- 4mg/0.1ml and Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Naloxone Market, By Route of Administration, 2016 – 2026 (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Intranasal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Intramuscular/Subcutaneous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Intravenous
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Naloxone Market, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Introduction
- Market Share Analysis, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, 2017–2026
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2016 – 2026, (US$ Mn)
- Introduction
- Global Naloxone Market, By Region, 2016 – 2026 (US$ Mn)
- Introduction
- Market Share Analysis, By Region, 2018 and 2026 (%)
- Y-o-Y Growth Analysis, For Regions, 2017–2026
- North America
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- U.S.
- Canada
- Europe
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Africa
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- Central Africa
- South Africa
- North Africa
- Middle East
- Market Size and Forecast, By Strength, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Distribution Channel, 2016 – 2026 (US$ Mn)
- Market Size and Forecast, By Country, 2016 – 2026 (US$ Mn)
- GCC
- Israel
- Rest of Middle East
- Introduction
- Competitive Landscape
- Heat Map Analysis
- Company Profiles
- Mylan N.V.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Indivior Plc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Adapt Pharma, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Amphastar Pharmaceuticals, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- INSYS Therapeutics, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mundipharma International Limited
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kaleo, Inc.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Kern Pharma, S.L.
- Company Overview
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Mylan N.V.
- Section
- References
- Research Methodology
- About us and Sales Contact
About Us:
Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients to achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having an office at global financial capital in the U.S. and sales consultants in the United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies to not-for-profit organizations, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837